Neurosurgical Review

, Volume 36, Issue 2, pp 259–266

Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients

  • Keiko Sugimoto
  • Joji Inamasu
  • Yoko Kato
  • Yasuhiro Yamada
  • Tsukasa Ganaha
  • Motoki Oheda
  • Natsuki Hattori
  • Eiichi Watanabe
  • Yukio Ozaki
  • Yuichi Hirose
Original Article

Abstract

Patients with aneurysmal subarachnoid hemorrhage (SAH) are frequently complicated by acute cardiac dysfunctions, including cardiac wall motion abnormality (WMA). Massive release of catecholamine into the systemic circulation after aneurysmal rupture is believed to result in WMA, and poor-grade SAH seems to be the most important risk factor. However, plasma catecholamine levels have rarely been measured in SAH patients with WMA, and previous studies indicated that the elevated levels might not necessarily predict WMA. The objective of this study is (1) to evaluate relationship between WMA and plasma catecholamine levels in poor-grade SAH patients in the acute phase and (2) to clarify clinical characteristics of SAH patients with WMA. Among 142 poor-grade (World Federation of Neurosurgical Societies grades IV and V) SAH patients, 48 underwent both transthoracic ultrasound and measurement of plasma catecholamine levels within 24 h of SAH onset. They were divided into WMA+ (n = 23) and WMA− (n = 25) groups, and intergroup comparison was made on demographics, plasma catecholamine levels, and outcomes. Plasma norepinephrine levels were significantly higher in WMA+ group than in WMA− group (2,098.4 ± 1,773.4 vs. 962.9 ± 838.9 pg/mL, p = 0.02), and the former showed significantly worse outcomes 90 days after admission. There were no intergroup differences in the plasma levels of epinephrine. Plasma norepinephrine levels were inversely correlated with left ventricular ejection fraction. Multivariate logistic regression analysis revealed that increased plasma norepinephrine levels were predictive of WMA, although age, female sex, and grade V SAH were not. This retrospective study highlights the role of norepinephrine in pathogenesis of SAH-induced WMA.

Keywords

Catecholamine Ejection fraction Norepinephrine Subarachnoid hemorrhage Wall motion abnormality 

References

  1. 1.
    Inamasu J, Miyatake S, Tomioka H, Suzuki M, Nakatsukasa M, Maeda N, Ito T, Arai K, Komura M, Kase K, Kobayashi K (2009) Subarachnoid haemorrhage as a cause of out-of-hospital cardiac arrest: a prospective computed tomography study. Resuscitation 80:977–9802PubMedCrossRefGoogle Scholar
  2. 2.
    Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Ohba S, Ichikizaki K (2002) Normokalemia and hyperglycemia in subarachnoid hemorrhage patients resuscitated from prehospital cardiopulmonary arrest. Resuscitation 54:255–258PubMedCrossRefGoogle Scholar
  3. 3.
    Inamasu J, Nakatsukasa M, Mayanagi K, Miyatake S, Sugimoto K, Hayashi T, Kato Y, Hirose Y (2012) Subarachnoid hemorrhage complicated with neurogenic pulmonary edema and takotsubo-like cardiomyopathy. Neurol Med Chir (Tokyo) 52:49–55CrossRefGoogle Scholar
  4. 4.
    Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF (2006) Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 105:264–270PubMedCrossRefGoogle Scholar
  5. 5.
    Stevens RD, Nyquist PA (2007) The systemic implications of aneurysmal subarachnoid hemorrhage. J Neurol Sci 261:143–156PubMedCrossRefGoogle Scholar
  6. 6.
    Sugimoto K, Watanabe E, Yamada A, Iwase M, Sano H, Hishida H, Ozaki Y (2008) Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage. Int Heart J 49:75–85PubMedCrossRefGoogle Scholar
  7. 7.
    Khush K, Kopelnik A, Tung P, Banki N, Dae M, Lawton M, Smith W, Drew B, Foster E, Zaroff J (2005) Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr 18:168–174PubMedCrossRefGoogle Scholar
  8. 8.
    Mayer SA, LiMandri G, Sherman D, Lennihan L, Fink ME, Solomon RA, DiTullio M, Klebanoff LM, Beckford AR, Homma S (1995) Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 83:889–896PubMedCrossRefGoogle Scholar
  9. 9.
    Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, Gress D, Drew B, Foster E, Parmley W, Zaroff J (2004) Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 35:548–551PubMedCrossRefGoogle Scholar
  10. 10.
    Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR (1992) Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery 31:42–501PubMedCrossRefGoogle Scholar
  11. 11.
    Brouwers PJ, Westenberg HG, Van Gijn J (1995) Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 58:614–617PubMedCrossRefGoogle Scholar
  12. 12.
    Grad A, Kiauta T, Osredkar J (1991) Effect of elevated plasma norepinephrine on electrocardiographic changes in subarachnoid hemorrhage. Stroke 22:746–749PubMedCrossRefGoogle Scholar
  13. 13.
    Kothavale A, Banki NM, Kopelnik A, Yarlagadda S, Lawton MT, Ko N, Smith WS, Drew B, Foster E, Zaroff JG (2006) Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 4:199–2057PubMedCrossRefGoogle Scholar
  14. 14.
    Naredi S, Lambert G, Edén E, Zäll S, Runnerstam M, Rydenhag B, Friberg P (2000) Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 31:901–906PubMedCrossRefGoogle Scholar
  15. 15.
    Tanabe M, Crago EA, Suffoletto MS, Hravnak M, Frangiskakis JM, Kassam AB, Horowitz MB, Gorcsan J 3rd (2008) Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol 102:1545–1550PubMedCrossRefGoogle Scholar
  16. 16.
    Masuda T, Sato K, Yamamoto S, Matsuyama N, Shimohama T, Matsunaga A, Obuchi S, Shiba Y, Shimizu S, Izumi T (2002) Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 33:1671–1676PubMedCrossRefGoogle Scholar
  17. 17.
    Moussouttas M, Lai EW, Dombrowski K, Huynh TT, Khoury J, Carmona G, DeCaro M, Pacak K (2011) CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Neurocrit Care 14:401–4069PubMedCrossRefGoogle Scholar
  18. 18.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548PubMedCrossRefGoogle Scholar
  19. 19.
    Jain R, Deveikis J, Thompson BG (2004) Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol 25:126–129PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Keiko Sugimoto
    • 1
  • Joji Inamasu
    • 2
  • Yoko Kato
    • 2
  • Yasuhiro Yamada
    • 2
  • Tsukasa Ganaha
    • 2
  • Motoki Oheda
    • 2
  • Natsuki Hattori
    • 2
  • Eiichi Watanabe
    • 3
  • Yukio Ozaki
    • 3
  • Yuichi Hirose
    • 2
  1. 1.Department of Medical TechnologyFujita Health University School of Health SciencesToyoakeJapan
  2. 2.Department of NeurosurgeryFujita Health University School of MedicineToyoakeJapan
  3. 3.Department of CardiologyFujita Health University School of MedicineToyoakeJapan

Personalised recommendations